This is a modification to invoke Option Year 1 for a contract for Sertraline HCL Tablets, with a performance period from June 28, 2022, through June 27, 2023. The description references several amendments to the original solicitation, which included changes to the solicitation date, the extension of a closing date, and the incorporation of updated clauses and specific tax provisions.